Rai Arpita, Kumar Ansul, Shree Priya, Haque Zeya Ul, Kumari Sneha, Yadav Satyendra Prasad, Mahuli Simpy Amit, Shamsi Shoa
Oral Medicine and Radiology, Dental College, Rajendra Institute of Medical Sciences (RIMS), Bariatu, Ranchi 834009 India.
CTVS Department, Rajendra Institute of Medical Sciences (RIMS), Bariatu, Ranchi 834009 India.
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):4125-4136. doi: 10.1007/s12070-023-03876-1. Epub 2023 May 17.
: To study the efficacy of Colchicine in the management of Oral Sub mucous Fibrosis (OSMF) through systematic review and meta-analysis. :An extensive literature search was conducted on databases such as PubMed, Cochrane Library database, LILACS, Google Scholar, CTRI, and Google search engine. The search comprises all articles published from 2013 to 2022. A total of 10 randomized control trial studies involving colchicine as one of the interventions were included. [CRD42022377674] :10 randomized control comprising 456 subjects were included. 3 studies are included in the meta-analysis comprising 90 subjects. All three studies show that there are significant differences between colchicine and other intervention regarding mouth opening and burning sensation. It indicates that Colchicine is significantly more effective in the reduction of burning sensation than other interventions used as a control in OSMF. : The evidence generated through this systemic review and meta-analysis suggest that the use of an oral form of colchicine is an effective measure in the management of OSMF, especially the subjective symptom such as burning sensation where as it is not found to be much effective in case of mouth opening. If colchicine is used as co drug along with conventional injection therapy better will the result. However there is marked diversity among the studies reviewed; therefore, the results of this review should be interpreted very carefully.
通过系统评价和荟萃分析研究秋水仙碱在口腔黏膜下纤维化(OSMF)治疗中的疗效。
在PubMed、Cochrane图书馆数据库、LILACS、谷歌学术、CTRI和谷歌搜索引擎等数据库上进行了广泛的文献检索。检索涵盖了2013年至2022年发表的所有文章。共纳入了10项将秋水仙碱作为干预措施之一的随机对照试验研究。[CRD42022377674]
纳入了10项包含456名受试者的随机对照试验。3项研究纳入荟萃分析,共90名受试者。所有三项研究均表明,秋水仙碱与其他干预措施在张口度和烧灼感方面存在显著差异。这表明秋水仙碱在减轻烧灼感方面比OSMF中用作对照的其他干预措施显著更有效。
通过该系统评价和荟萃分析得出的证据表明,口服秋水仙碱是治疗OSMF的有效措施,尤其是在减轻烧灼感等主观症状方面,而在张口度方面效果不太明显。如果秋水仙碱与传统注射疗法联合使用,效果会更好。然而,所审查的研究之间存在明显差异;因此,应非常谨慎地解释本评价的结果。